Second Affiliated Hospital

Company snapshot

Originally known as Hangzhou Guangji Hospital (meaning “spreading benevolence around the world” or “universal benevolence”), the Second Affiliated Hospital Zhejiang University School of Medicine (SAHZU) was founded in 1869, and was considered the best hospital in the Far East then. As the cradle of western medicine in Zhejiang, SAHZU educated a large number of medical talents, and several health c

• 2 active pipeline program(s) linked via ClinicalTrials.gov.
• 2 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Second Affiliated Hospital. Not investment advice.

• What is Second Affiliated Hospital?

  Second Affiliated Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Multiple System Atrophy, Asthma. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTri

• Is Second Affiliated Hospital publicly traded?

  Second Affiliated Hospital appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Second Affiliated Hospital develop or market?

  We link 4 drug profile(s) where Second Affiliated Hospital is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/second-affiliated-hospital-school-of-medicine-zhejiang-university#company-drugs.

• What are the latest developments for Second Affiliated Hospital?

  In the last 12 months our linked public records show 2 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Second Affiliated Hospital focus on?

  Second Affiliated Hospital focuses on Multiple System Atrophy, Asthma based on our analysis of their pipeline programs and drug development activities.